9 Rare diseases9.1 Urinary glycosaminoglycan in the course of FMF9.2 Epithelial cell-derived neutrophil activator (ENA-78) levels in patients with FMF9.3 Five cases of juvenile idiopathic arthritis and the velocardiofacial (22q11) syndrome9.4 Effects of …